Indication
Eracef® vet injection is indicated for the following infections caused by susceptible organisms: Respiratory Tract Infections (lungs), skin & its stuctural infections, bone & joint infections, Gastro-intestinal tract infections (Intra abdominal), Acute bacterial otitis media and urinary
tract infections. In acute and severe infections caused by sensitive micro-organisms viz Mastitis, Metritis, Septicemia, Pneumonia, Meningitis, Haemorrhagic Septicemia, Black Quarter, Anthrax, Foot Rot, Pre Operative Prophylaxis & Post Operative Infections etc.
Dosage & Administration
Ceftriaxone may be administered by deep intramuscular injection or slow intravenous injection.
Species |
Dose |
Administer IV With WFI |
Administer IM With Lidocaine |
Large Animals (Cattle, Horse & Camel) |
10 mg/kg body weight |
1 ml/10 kg body weight |
1 ml/28 kg body weight |
Small Animals (Calf & Goat) |
15-50 mg/kg body weight |
1.5-5 ml/10 kg body weight |
1 ml/6-20 kg body weight |
Pet Animals (Dogs, Cats) |
15-50 mg/kg body weight |
1.5-5 ml/10 kg body weight |
1 ml/6-20 kg body weight |
Zoo Animals |
10 mg/kg body weight |
1 ml/10 kg body weight |
1 ml/28 kg body weight |
Or prescribed by the registered veterinarian.
Preparation of Solutions:
For intramuscular injection: Add 3.5 ml of Lidocaine Hydrochloride BP 1% injection to 1 g Eracef ® vet vial whereas 7 ml of Lidocaine Hydrochloride BP 1% injection to 2 g Eracef® vet vial and shake the vial well until the powder is dissolved properly. For intravenous injection: Add 10 ml of Water for Injection BP to 1 g Eracef® vet vial whereas 20 ml of Water for Injection BP to 2 g Eracef® vet vial and shake the vial well until the powder is dissolved properly. The use of freshly reconstituted solution is recommended. However, it maintains
p otency for at least 6 hours at room temperature or 24 hours at 5oC.
Withdrawal Period: There are no adequate and well-controlled studies available.
Precautions
Do not administer Eracef® vet (Ceftriaxone) IV dissolved with 1% Lidocaine Hydrochloride injection BP.
Pregnancy/Reproduction: Studies in laboratory animals have not shown the cephalosporins to cause adverse effects in the fetus.
Lactation: Cephalosporins are distributed into milk; however when Cephalosporins are administered systemically at accepted doses, therapeutic concentrations are not reached in milk.
Product Details
Related Products
Cefa-1 Vet Powder
Cefalexin Monohydrate BPAntibiotic
DO-2 100 gm
Doxycycline 2% & Oxytetracycline 1%Antibiotic
Doty Vet Powder
Tylosin Tartrate 20% & Doxycycline 10%Antibiotic
Fimox Vet
Amoxicillin Sodium & Amoxicillin TrihydrateAntibiotic